Order no. | Antibody specificity/ reagent/ analyte | Ig class | Substrate | Species | Format | |
---|---|---|---|---|---|---|
Varicella zoster virus (VZV) | IgA | semi-quantitative | ||||
Varicella zoster virus (VZV) | IgG | 10/100/500/5000 IU/l | ||||
Varicella zoster virus (VZV) incl. IgG/RF absorbent | IgM | semi-quantitative | ||||
Varicella zoster virus (VZV) avidity determination | IgG | 10/100/500/5000 IU/l | ||||
Varicella zoster virus (VZV) glycoprotein incl. IgG/RF absorbent | IgM | semi-quantitative | ||||
Varicella zoster virus (VZV) antibody determination in CSF | IgA | 5/25/50/100 U | ||||
Varicella zoster virus (VZV) antibody determination in CSF | IgG | 5/25/50/100/175/230 U | ||||
"TO.R.C.H. 10" (Toxoplasma gondii, Rubella virus, CMV, HSV-1, HSV-2, Bordetella pertussis, Chlamydia trachomatis, Parvovirus B19, Treponema pallidum, VZV separately) | IgG | EUROLINE | ||||
Varicella zoster virus (VZV) | IgA IgG IgM avidity test | infected cells | EU 168 | |||
Exanthema Profile 1 (consisting of 21 different substrates) | IgG IgM | field A: verification BIOCHIP, HHV-6, Rubella virus*, Measles virus, Mumps virus field B: VZV, EBV-CA, EBV-EA, Treponema pallidum field C: HSV-1 and -2, Coxsackie virus type B1 and A9 field D: Echo virus type 7, Borrelia afzelii, burgdorferi (CH), garinii field E: CMV, Candida albicans, krusei*, tropicalis* | ||||
Central Nervous System Profile 1 (consisting of 21 different substrates) | IgG IgM | field A: verification BIOCHIP, Rubella virus*, Measles virus, Mumps virus, VZV field B: Adenovirus type 3, EBV-CA, Treponema pallidum, Toxoplasma gondii field C: HSV-1 and -2, Coxsackie virus type B1 and A7 field D: Echo virus type 7, Borr. afzelii, burgdorferi (CH), garinii field E: CMV, Haemophilus influenzae*, Listeria monocytogenes 1/2a und 4b | ||||
Infectious Arthritis Profile 1 (consisting of 13 different substrates) | IgG IgM | field A: verification BIOCHIP, VZV, Influenza virus type A (H1N1 and H3N2) and B field B: Yersinia enterocolitica O:3*, O:6*, O:9*, Toxoplasma gondii field C: Borrelia afzelii, burgdorferi (CH), garinii, Chlamydia trachomatis | ||||
CSQ pair of controls anti-VZV (IgG) | IgG | |||||
antibodies against Varicella zoster virus (VZV) IgA positive control | IgA | |||||
Varicella zoster virus (VZV) negative control | IgA, IgG, IgM | |||||
antibodies against Varicella zoster virus (VZV) IgG positive control | IgG | |||||
antibodies against Varicella zoster virus (VZV) IgM positive control | IgM | |||||
high-avid antibodies against Varicella zoster virus (VZV) IgG positive control | avidity test | |||||
low-avid antibodies against Varicella zoster virus (VZV) IgG positive control | avidity test |